{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:08:40Z","timestamp":1785802120650,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutritional Biochemistry"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jnutbio.2016.10.008","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T11:30:29Z","timestamp":1477135829000},"page":"32-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Metabolic outcomes of bergamot polyphenolic fraction administration in patients treated with second-generation antipsychotics: a pilot study"],"prefix":"10.1016","volume":"40","author":[{"given":"Antonio","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Pandolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Crucitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Maisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco A.","family":"Zoccali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria Anna","family":"Muscatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jnutbio.2016.10.008_bb0005","series-title":"Pharmacovigilance in psychiatry","first-page":"167","article-title":"Safety and tolerability of antipsychotics","author":"Jann","year":"2016"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2014.11.008","article-title":"Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms","volume":"25","author":"Gon\u00e7alves","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0015","first-page":"1","article-title":"An update of safety of clinically used atypical antipsychotics","volume":"4","author":"Orsolini","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.9740\/mhc.2016.07.178","article-title":"Atypical antipsychotics: a review on the prevalence, monitoring, and management of their metabolic and cardiovascular side effects","volume":"6","author":"Wei Xin Chong","year":"2016","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment \u2014 pharmacological mechanisms","volume":"125","author":"Reynolds","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-244X-11-118","article-title":"Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects? A cross-sectional study","volume":"11","author":"Misawa","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0035","first-page":"8","article-title":"Antipsychotic medications: metabolic and cardiovascular risk","volume":"68","author":"Newcomer","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0045","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2133\/dmpk.20.368","article-title":"Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus","volume":"20","author":"Matsui-Sakata","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0050","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1034\/j.1600-0447.2000.101006416.x","article-title":"Atypical antipsychotics and weight gain \u2014 a systematic review","volume":"101","author":"Taylor","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0055","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.lfs.2006.06.016","article-title":"Antipsychotic induced metabolic abnormalities: an interaction study with various PPAR modulators in mice","volume":"79","author":"Arulmozhi","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1194\/jlr.M026948","article-title":"Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro","volume":"54","author":"Canfr\u00e1n-Duque","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0065","first-page":"171","article-title":"Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management","volume":"5","author":"Krill","year":"2014","journal-title":"Adolesc Health Med Ther"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0070","doi-asserted-by":"crossref","first-page":"970730","DOI":"10.1155\/2015\/970730","article-title":"Efficacy of adjunctive treatments added to olanzapine or clozapine for weight control in patients with schizophrenia: a systematic review and meta-analysis","volume":"2015","author":"Choi","year":"2015","journal-title":"Scientific World Journal"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0075","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1755-5922.2010.00179.x","article-title":"Nutraceuticals in diabetes and metabolic syndrome","volume":"28","author":"Dav\u00ec","year":"2010","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1271\/bbb.70.178","article-title":"Flavonoid composition of fruit tissues of citrus species","volume":"70","author":"Nogata","year":"2006","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0085","first-page":"951","article-title":"Citrus bergamia juice: phytochemical and technological studies","volume":"6","author":"Picerno","year":"2011","journal-title":"Nat Prod Commun"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.fitote.2010.10.014","article-title":"Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies","volume":"82","author":"Mollace","year":"2011","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijcard.2013.08.125","article-title":"Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia","volume":"170","author":"Gliozzi","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4236\/abc.2014.42017","article-title":"The effect of bergamot-derived polyphenolic fraction on LDL small dense particles and nonalcoholic fatty liver disease in patients with MS","volume":"4","author":"Gliozzi","year":"2014","journal-title":"Adv Biol Chem"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0105","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jff.2013.12.029","article-title":"Hypocholesterolaemic activity of 3-hydroxy-3-methyl-glutaryl flavanones enriched fraction from bergamot fruit (Citrus bergamia): \u201cin vivo\u201d studies","volume":"7","author":"Di Donna","year":"2014","journal-title":"J Funct Foods"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5567\/pharmacologia.2015.120.124","article-title":"Bergamot polyphenols: a phytotherapeutic approach to hyperlipidemia and hypercholesterolemia control","volume":"6","author":"Ciccone","year":"2015","journal-title":"Pharmacologia"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fphar.2015.00299","article-title":"Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: a 6 months prospective study","volume":"6","author":"Toth","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0125","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0130","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European guidelines on cardiovascular disease prevention in clinical practice (version 2012)","volume":"33","author":"The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0135","first-page":"151","article-title":"2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"29","author":"Anderson","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0140","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0145","first-page":"15S","article-title":"Metabolic issues and cardiovascular disease in patients with psychiatric disorders","volume":"118","author":"Casey","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0150","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1192\/bjp.184.47.s80","article-title":"Antipsychotics and diabetes: review of non-prospective data","volume":"47","author":"Haddad","year":"2004","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0155","first-page":"12","article-title":"Pharmacological mechanisms underlying the association of antipsychotics with metabolic disorders","volume":"40","author":"Miron","year":"2014","journal-title":"Curr Health Sci J"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/0253-7176.119471","article-title":"Metabolic syndrome in schizophrenia","volume":"35","author":"Malhotra","year":"2013","journal-title":"Indian J Psychol Med"},{"key":"10.1016\/j.jnutbio.2016.10.008_bb0165","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.mam.2010.09.006","article-title":"Basic biochemical mechanisms behind the health benefits of polyphenols","volume":"31","author":"Fraga","year":"2010","journal-title":"Mol Aspects Med"}],"container-title":["The Journal of Nutritional Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286316302935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286316302935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:20:05Z","timestamp":1760628005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955286316302935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":33,"alternative-id":["S0955286316302935"],"URL":"https:\/\/doi.org\/10.1016\/j.jnutbio.2016.10.008","relation":{},"ISSN":["0955-2863"],"issn-type":[{"value":"0955-2863","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic outcomes of bergamot polyphenolic fraction administration in patients treated with second-generation antipsychotics: a pilot study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutritional Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnutbio.2016.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}